FDA NDA for bezuclastinib targets post-imatinib GIST, leveraging Real-Time Oncology Review and prior breakthrough therapy ...
In lymphedema, dermatitis and excoriation can precipitate inflammatory swelling and increase cellulitis risk, making barrier ...
The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care ...
A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
Christine Fader shares how her husband’s past trauma shaped his cancer treatment experience and why awareness and patient ...
For people diagnosed with actual early stage breast cancer, there would be an end date to their drug therapy too. Maybe a year of Herceptin (trastuzumab), maybe five years of anti-estrogen, something, ...
"Multiple myeloma is a marathon, not a sprint," Annamarie emphasized in an interview with CURE. To avoid the exhaustion that ...
Multiple myeloma survivor JP Kealy and wife Annamarie share how to avoid cancer burnout and why this journey is a marathon, not a sprint.
The phase 3 study, known as Neo-Healer or KN026–004, was an open-label, multicenter trial that randomly assigned ...
A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results